EP Patent

EP3054957A4 — Hematocrit modulation through needle assisted jet injection of testosterone

Assigned to Antares Pharma Inc · Expires 2017-03-15 · 9y expired

What this patent protects

Patent listed against testosterone-enanthate.

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: EP3054957A4
Jurisdiction: EP
Classification: —
Expires: 2017-03-15
Drug substance claim: No
Drug product claim: No
Assignee: Antares Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.